PLUSTICK MANAGEMENT LLC CRISPR Therapeutics AG Transaction History

PLUSTICK MANAGEMENT LLC portfolio value:

$3.26M
portfolio value

PLUSTICK MANAGEMENT LLC quarter portfolio value change:

+7.54%
quarter

CRISPR Therapeutics AG 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 229K $65.35 50K
Q2 2022 share 0.00% 0 shares -100K $60.77 50K
Q1 2022 share 0.00% 0 shares -650K $62.77 50K
Q4 2021 share Increase 0.00% 50K shares 3.78M $78.85 50K